MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4962 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2024-09-26 (massdevice.com)
Medtronic renal denervation system recognized on ‘Change the World’ list
Medtronic announced today that Fortune named it to its 2024 "Change the World" list for its Symplicity blood pressure procedure.
Read more
2024-04-16 (theglobeandmail.com)
Medtronic pursues ambitious targets on climate action
Francis Dufresne, senior regional business director at Medtronic, supporting his son's soccer game.
Read more
2023-12-04 (massdevice.com)
Aptar wins FDA contract to study low global warning potential metered dose inhalers
Aptar Pharma announced today that it entered into a contract with the FDA to work on low global warming potential (low-GWP) inhalers.
Read more
(csrwire.com)
Medtronic Signs Commitment to Science Based Targets
With this formal commitment to SBTi, Medtronic recognizes the crucial role that the business community can play in minimizing the risk that climate change poses.
Read more